By Johanna Urbancik
Published on
19/06/2026 - 9:06 GMT+2
The United States has launched a trade investigation against Germany over drug pricing. According to several media reports, Washington wants to examine whether innovative medicines are systematically under-remunerated on the German market, leaving US patients to shoulder a comparatively high share of research and development costs.
The announcement was made on Thursday in a statement from the office of the US Trade Representative, Jamieson Greer, who, according to the Reuters news agency, launched the investigation on suspicion that Germany is paying too little for innovative medicines. "I am particularly concerned by reports that Germany is fast-tracking legislation that would further reduce spending on innovative medicines," Greer said.
